Molecule is building a marketplace for pharma and biotech, where R&D moves from siloed development pipelines to a collaborative open IP and data platform. The overall market for drug discovery is huge and growing at a rapid pace. Yet, the current drug development process remains slow and inefficient. Molecule aims at disrupting drug development, IP management and fundraising by building a collaborative open pharma ecosystem.